AXSM vs. MATW
AXSM (Axsome Therapeutics, Inc.) and MATW (Matthews International Corporation) are both stocks. AXSM operates in Biotechnology (Healthcare), while MATW operates in Conglomerates (Industrials). Over the past 10 years, AXSM returned 42.66%/yr vs -4.38%/yr for MATW. At a 0.17 correlation, their price movements are largely independent.
Performance
AXSM vs. MATW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AXSM achieves a 35.70% return, which is significantly higher than MATW's 1.87% return. Over the past 10 years, AXSM has outperformed MATW with an annualized return of 42.66%, while MATW has yielded a comparatively lower -4.38% annualized return.
AXSM
- 1D
- -1.06%
- 1M
- 5.03%
- YTD
- 35.70%
- 6M
- 60.21%
- 1Y
- 146.15%
- 3Y*
- 41.16%
- 5Y*
- 28.89%
- 10Y*
- 42.66%
MATW
- 1D
- -0.91%
- 1M
- -2.39%
- YTD
- 1.87%
- 6M
- 2.30%
- 1Y
- 29.23%
- 3Y*
- -9.69%
- 5Y*
- -2.96%
- 10Y*
- -4.38%
AXSM vs. MATW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 35.70% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
MATW Matthews International Corporation | 1.87% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
Correlation
The correlation between AXSM and MATW is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.17 |
The correlation between AXSM and MATW shifts across timeframes, from 0.08 (1 year) to 0.19 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AXSM:
-$3.74
MATW:
$0.41
AXSM:
17.61
MATW:
0.51
AXSM:
$708.24M
MATW:
$1.21B
AXSM:
$655.82M
MATW:
$432.86M
AXSM:
-$172.72M
MATW:
$201.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXSM vs. MATW — Risk / Return Rank
AXSM
MATW
AXSM vs. MATW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AXSM | MATW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.66 | ||
| Sortino ratioReturn per unit of downside risk | +3.44 | ||
| Omega ratioGain probability vs. loss probability | 1.59 | 1.17 | +0.43 |
| Calmar ratioReturn relative to maximum drawdown | 7.95 | 1.85 | +6.10 |
| Martin ratioReturn relative to average drawdown | 23.42 | 4.26 | +19.16 |
Loading charts...
Drawdowns
AXSM vs. MATW - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for AXSM and MATW.
Loading charts...
Drawdown Indicators
| AXSM | MATW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.65% | -75.27% | -11.38% |
Max Drawdown (1Y)Largest decline over 1 year | -18.50% | -15.87% | -2.63% |
Max Drawdown (3Y)Largest decline over 3 years | -34.83% | -58.68% | +23.85% |
Max Drawdown (5Y)Largest decline over 5 years | -72.91% | -58.68% | -14.23% |
Max Drawdown (10Y)Largest decline over 10 years | -81.26% | -75.27% | -5.99% |
Current DrawdownCurrent decline from peak | -2.87% | -55.94% | +53.07% |
Average DrawdownAverage peak-to-trough decline | -39.40% | -24.75% | -14.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.27% | 6.88% | -0.61% |
Volatility
AXSM vs. MATW - Volatility Comparison
Axsome Therapeutics, Inc. (AXSM) and Matthews International Corporation (MATW) have volatilities of 8.92% and 8.62%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXSM | MATW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.92% | 8.62% | +0.30% |
Volatility (6M)Calculated over the trailing 6-month period | 33.16% | 21.67% | +11.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.74% | 33.95% | +7.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.26% | 36.34% | +33.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.40% | 36.97% | +53.43% |
Dividends
AXSM vs. MATW - Dividend Comparison
AXSM has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 3.89%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MATW Matthews International Corporation | 3.89% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
Financials
AXSM vs. MATW - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. MATW - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
MATW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Matthews International Corporation reported a gross profit of 101.98M and revenue of 258.62M. Therefore, the gross margin over that period was 39.4%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
MATW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Matthews International Corporation reported an operating income of -3.18M and revenue of 258.62M, resulting in an operating margin of -1.2%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
MATW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Matthews International Corporation reported a net income of -21.83M and revenue of 258.62M, resulting in a net margin of -8.4%.
Frequently Asked Questions
AXSM and MATW have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXSM has higher volatility (8.92%) compared to MATW (8.62%). In terms of maximum drawdown, AXSM dropped -86.65% vs MATW's -75.27%.
AXSM currently has the higher Sharpe Ratio (3.53 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXSM and MATW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer